Project Details
Project Description
| Status | Finished |
|---|---|
| Effective start/end date | 8/10/19 → 7/10/24 |
Keywords
- clinical trial
- treatment efficacy
- lymphoma
- leukemia
Clinical Trial Phase
- Phase II
Phase 2 Study of the Combination of Ibrutinib Plus Venetoclax in Subjects With Treatment-Naïve Chronic Lymphocytic Leukaemia / Small Lymphocytic Lymphoma
- Opat, Stephen (Primary Chief Investigator (PCI))
Project: Research